Market Research & Insights
Top concern and key challenges for Australian healthcare and pharma leaders
A recent PwC report revealed rising costs and their ensuing pressures on key stakeholders as the top concern of healthcare and pharma leaders. At the same time, more than 80% of healthcare and pharma organisations are doing more with fewer resources.
So what is required to lean into these concerns? What expertise and added value can the relevant service providers and suppliers offer to support the industry?
Key challenges in Australia, according to PwC report
Challenge 1: Turning inward to reduce the talent gap
Leaders see concerns around the availability of key internal skills. Many businesses are having to reflect on how to attract, train and retain their workforce. People costs are rising more than expected as a result, so is it time to think differently about ways to solve their skills challenge?
Challenge 2: Mountains of data, molehills of intelligence
Leaders are working to bridge the gap of translating a deluge of data into better decision making. Only 7% believe their customer data is comprehensive and finding the right data talent is a significant challenge.
Challenge 3: AI at the tipping point
Artificial Intelligence (AI) has the potential to supercharge growth, but without clean, relevant, and labeled data – and the workforce to harness this – organisations are being hindered in their efforts to move aggressively on AI.

What do you think? Share your views to help the Pharma, MedTech and Biotech industries.
With more than 80% of healthcare and pharma organisations doing more with fewer resources, how is superior value delivered by the top service providers and suppliers to support you in your role in Pharma, Biotech or MedTech? What gaps can be addressed to better assist you?
Help the Pharma, MedTech and Biotech industries by sharing your input in this anonymous 2 minutes survey. You may click here to take the survey or alternately scroll down this page to share your views.
You may opt in to receive the aggregated results at the end of the survey.
Create your own user feedback surveyNews & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More